IN2013CN02996A - - Google Patents
Download PDFInfo
- Publication number
- IN2013CN02996A IN2013CN02996A IN2996CHN2013A IN2013CN02996A IN 2013CN02996 A IN2013CN02996 A IN 2013CN02996A IN 2996CHN2013 A IN2996CHN2013 A IN 2996CHN2013A IN 2013CN02996 A IN2013CN02996 A IN 2013CN02996A
- Authority
- IN
- India
- Prior art keywords
- desmosterol
- disease
- alzheimer
- cognitive impairment
- mild cognitive
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/203332—Hydroxyl containing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Desmosterol alone the combination of desmosterol and amyloid beta the combination of desmosterol and gelsolin and the combination of desmosterol amyloid beta and gelsolin can be used as in blood biomarkers for Alzheimer s disease or mild cognitive impairment. Provided are: a method using these biomarkers for evaluating the effect of candidate substances for treatment agents for Alzheimer s disease or mild cognitive impairment; a method for assisting in the diagnosis of Alzheimer s disease or mild cognitive impairment; and a method for diagnosing Alzheimer s disease or mild cognitive impairment.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010235203 | 2010-10-20 | ||
US201061424885P | 2010-12-20 | 2010-12-20 | |
JP2010282938 | 2010-12-20 | ||
PCT/JP2011/064487 WO2012053255A1 (en) | 2010-10-20 | 2011-06-23 | Biomarker for alzheimer's disease or mild cognitive impairment |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013CN02996A true IN2013CN02996A (en) | 2015-08-14 |
Family
ID=45974981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2996CHN2013 IN2013CN02996A (en) | 2010-10-20 | 2011-06-23 |
Country Status (10)
Country | Link |
---|---|
US (1) | US9581604B2 (en) |
EP (1) | EP2631646B1 (en) |
JP (1) | JP5695075B2 (en) |
AU (1) | AU2011319319B2 (en) |
BR (1) | BR112013009592A2 (en) |
CA (1) | CA2814385C (en) |
IN (1) | IN2013CN02996A (en) |
NZ (1) | NZ609324A (en) |
RU (1) | RU2563987C2 (en) |
WO (1) | WO2012053255A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201212084D0 (en) * | 2012-07-06 | 2012-08-22 | Randox Lab Ltd | Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment |
US20180024150A1 (en) * | 2015-03-06 | 2018-01-25 | Niigata University | Biomarker of dementia with lewy bodies |
NO3171174T3 (en) * | 2015-11-20 | 2018-03-24 | ||
CN114410774A (en) * | 2022-02-17 | 2022-04-29 | 杭州怡健医疗科技有限公司 | Risk assessment method applied to Alzheimer's disease |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003088811A2 (en) * | 2002-04-16 | 2003-10-30 | The Brigham And Women's Hospital, Inc. | Gelsolin as a prognostic marker of artherosclerotic diseases |
JPWO2007097461A1 (en) | 2006-02-27 | 2009-07-16 | 国立大学法人 熊本大学 | Antibody for hepatitis C treatment |
US7645748B2 (en) | 2006-04-03 | 2010-01-12 | Forbes Medi-Tech Inc. | Sterol/stanol phosphorylnitroderivatives and use thereof |
RU2356058C2 (en) | 2006-11-27 | 2009-05-20 | Александр Васильевич Мальцев | Method of amyloidosis diagnostics in patients with alzheimerts disease and set of means for its realisation |
-
2011
- 2011-06-23 AU AU2011319319A patent/AU2011319319B2/en not_active Ceased
- 2011-06-23 US US13/880,475 patent/US9581604B2/en active Active
- 2011-06-23 IN IN2996CHN2013 patent/IN2013CN02996A/en unknown
- 2011-06-23 JP JP2012539625A patent/JP5695075B2/en not_active Expired - Fee Related
- 2011-06-23 CA CA2814385A patent/CA2814385C/en not_active Expired - Fee Related
- 2011-06-23 NZ NZ609324A patent/NZ609324A/en not_active IP Right Cessation
- 2011-06-23 RU RU2013122853/15A patent/RU2563987C2/en not_active IP Right Cessation
- 2011-06-23 BR BR112013009592A patent/BR112013009592A2/en not_active Application Discontinuation
- 2011-06-23 EP EP11834097.5A patent/EP2631646B1/en active Active
- 2011-06-23 WO PCT/JP2011/064487 patent/WO2012053255A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2631646A1 (en) | 2013-08-28 |
BR112013009592A2 (en) | 2016-07-12 |
RU2013122853A (en) | 2014-11-27 |
US9581604B2 (en) | 2017-02-28 |
AU2011319319A1 (en) | 2013-05-02 |
US20130266589A1 (en) | 2013-10-10 |
NZ609324A (en) | 2014-09-26 |
RU2563987C2 (en) | 2015-09-27 |
EP2631646B1 (en) | 2016-10-19 |
JPWO2012053255A1 (en) | 2014-02-24 |
JP5695075B2 (en) | 2015-04-01 |
CA2814385C (en) | 2017-10-24 |
CA2814385A1 (en) | 2012-04-26 |
WO2012053255A1 (en) | 2012-04-26 |
AU2011319319B2 (en) | 2015-07-30 |
EP2631646A4 (en) | 2014-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013022493A2 (en) | equipment and method for examining, diagnosing or assisting in the diagnosis and treatment of functional vision problems | |
UA101167C2 (en) | Pharmaceutical composition useful for the treatment of ocular disease | |
EA201400491A1 (en) | ACCOMPANYING DIAGNOSTICS FOR THERAPY WITH ANTIHIALURON AGENT AND METHODS | |
WO2011064225A8 (en) | Novel diagnostic method for the diagnosis of alzheimer's disease or mild cognitive impairment | |
WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
WO2012031008A3 (en) | Cancer-related biological materials in microvesicles | |
IL222252A (en) | System, assembly and method for the detection and diagnosis of biological rhythm disorders | |
BR112014018592A2 (en) | composition and method for the diagnosis and treatment of diseases associated with neuronal degeneration | |
EP2222355A4 (en) | Meibomian gland intraductal diagnostic and treatment methods and related apparatus | |
SG179095A1 (en) | Novel assay for the detection of amyloid beta peptides | |
WO2014036495A3 (en) | Diagnostic assays and kits for detection of folate receptor 1 | |
HK1145087A1 (en) | Diagnostic agent | |
EP2240077A4 (en) | System and method of cosmetic analysis and treatment diagnosis | |
EP2631649A4 (en) | Method and device for the rapid diagnosis of diseases in faecal samples | |
EP2323680A4 (en) | Proteins for use in diagnosing and treating infection and disease | |
EP2509488A4 (en) | Methods and arrangements for analysis, diagnosis, and treatment monitoring of vocal folds by optical coherence tomography | |
WO2016040891A3 (en) | In vitro compositions comprising human sample and amyloid targeting agent | |
EP2260107A4 (en) | Assays for diagnosing and evaluating treatment options for pompe disease | |
WO2013164763A3 (en) | A biological complex specific for alzheimer's disease detection in vitro and use thereof | |
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
IN2013CN02996A (en) | ||
WO2012075023A3 (en) | Neoantibodies for diagnosing tissue injury | |
WO2012004276A3 (en) | Multiprotein biomarkers of amyotrophic lateral sclerosis in peripheral blood mononuclear cells, diagnostic methods and kits | |
IT1400684B1 (en) | IMAGING METHOD AND DEVICE FOR THE MONITORING OF AN EXAMINED BODY. | |
WO2013064702A3 (en) | Probes for diagnosis and monitoring of neurodegenerative disease |